Laura Carter's most recent trade in Gossamer Bio Inc was a trade of 157,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 20, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gossamer Bio Inc | Laura Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2023 | 157,500 | 157,500 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Laura Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 16 Mar 2023 | 6,029 | 76,263 (0%) | 0% | 1.1 | 6,620 | Common Stock |
| Gossamer Bio Inc | Laura Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.07 per share. | 24 Oct 2022 | 4,876 | 82,292 (0%) | 0% | 12.1 | 58,868 | Common Stock |
| Gossamer Bio Inc | Laura Carter | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 7.21 per share. | 15 Jul 2022 | 6,934 | 87,168 (0%) | 0% | 7.2 | 49,994 | Common Stock |
| Gossamer Bio Inc | Laura Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.25 per share. | 01 Jul 2022 | 8,808 | 80,234 (0%) | 0% | 8.2 | 72,648 | Common Stock |
| Gossamer Bio Inc | Laura Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.20 per share. | 04 May 2022 | 1,262 | 89,042 (0%) | 0% | 7.2 | 9,086 | Common Stock |
| Gossamer Bio Inc | Laura Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.28 per share. | 16 Mar 2022 | 5,002 | 90,304 (0%) | 0% | 8.3 | 41,407 | Common Stock |
| Gossamer Bio Inc | Laura Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 190,000 | 190,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Laura Carter | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.25 per share. | 25 Oct 2021 | 2,377 | 95,306 (0%) | 0% | 12.2 | 29,118 | Common Stock |
| Gossamer Bio Inc | Laura Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 25,000 | 97,683 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Laura Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 31,750 | 31,750 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Laura Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 10,820 | 72,683 (0%) | 0% | 0 | Common Stock |